Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension
Ulrike Raff(Friedrich-Alexander-Universität Erlangen-Nürnberg), Roland E. Schmieder(Universitätsklinikum Erlangen), Stephan Achenbach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Johannes Schwab(MRC Laboratory of Molecular Biology), I Bär(Nuremberg Hospital), Bernhard M. W. Schmidt(Medizinische Hochschule Hannover), Thomas Schwarz(MRC Laboratory of Molecular Biology)
Cited by 52
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease
|Journal of the American College of Cardiology|2014|1.5k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k